Literature DB >> 2658779

Characterization of beta-lactamases.

K Bush1.   

Abstract

Mesh：

Substances：

Year:  1989        PMID： 2658779      PMCID： PMC171476          DOI： 10.1128/AAC.33.3.259

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  39 in total

1.  6-beta-Iodopenicillanate as a probe for the classification of beta-lactamases.

Authors:  F De Meester; J M Frère; S G Waley; S J Cartwright; R Virden; F Lindberg
Journal:  Biochem J       Date:  1986-11-01       Impact factor: 3.857

2.  Molecular cloning and DNA homology of plasmid-mediated beta-lactamase genes.

Authors:  R C Levesque; A A Medeiros; G A Jacoby
Journal:  Mol Gen Genet       Date:  1987-02

Review 3.  Methodology for the study of beta-lactamases.

Authors:  K Bush; R B Sykes
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

4.  Do beta-lactamases 'trap' cephalosporins?

Authors:  D M Livermore
Journal:  J Antimicrob Chemother       Date:  1985-05       Impact factor: 5.790

5.  Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873.

Authors:  Y Saino; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

6.  Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase.

Authors:  D Sirot; J Sirot; R Labia; A Morand; P Courvalin; A Darfeuille-Michaud; R Perroux; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

7.  Development of natural and synthetic DNA probes for OXA-2 and TEM-1 beta-lactamases.

Authors:  M Boissinot; J Mercier; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

8.  Site-saturation studies of beta-lactamase: production and characterization of mutant beta-lactamases with all possible amino acid substitutions at residue 71.

Authors:  S C Schultz; J H Richards
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

9.  Purification of beta-lactamases by affinity chromatography on phenylboronic acid-agarose.

Authors:  S J Cartwright; S G Waley
Journal:  Biochem J       Date:  1984-07-15       Impact factor: 3.857

Review 10.  beta-Lactamase inhibitors.

Authors:  S J Cartwright; S G Waley
Journal:  Med Res Rev       Date:  1983 Oct-Dec       Impact factor: 12.944
View more
  88 in total

1.  In vitro activities of the potent, broad-spectrum carbapenem MK-0826 (L-749,345) against broad-spectrum beta-lactamase-and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli clinical isolates.

Authors:  J Kohler; K L Dorso; K Young; G G Hammond; H Rosen; H Kropp; L L Silver
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Antibacterial activity of RU44790, a new N-tetrazolyl monocyclic beta-lactam.

Authors:  J F Chantot; M Klich; G Teutsch; A Bryskier; P Collette; A Markus; G Seibert
Journal:  Antimicrob Agents Chemother       Date:  1992-08       Impact factor: 5.191

3.  Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay.

Authors:  G A Papanicolaou; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

4.  OHIO-1 beta-lactamase is part of the SHV-1 family.

Authors:  D M Shlaes; C Currie-McCumber; A Hull; I Behlau; M Kron
Journal:  Antimicrob Agents Chemother       Date:  1990-08       Impact factor: 5.191

Review 5.  Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

Review 6.  The treatment of severe intra-abdominal infections: the role of piperacillin/tazobactam.

Authors:  C E Nord
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

7.  BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.

Authors:  R J Wallace; V A Steingrube; D R Nash; D G Hollis; C Flanagan; B A Brown; A Labidi; R E Weaver
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

8.  Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases.

Authors:  D J Payne; R Cramp; D J Winstanley; D J Knowles
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Antimicrobial activity and disk diffusion susceptibility testing of Ro 40-6890, the active metabolite of the new cephalosporin ester, Ro 41-3399.

Authors:  M A Pfaller; A L Barry; P C Fuchs
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

Review 10.  Beta-lactamases: current situation and clinical importance.

Authors:  J Garau
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.